DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

SAW PALMETTO

Search structure
Synonyms:
Abal fructus
Brahea serrulata fruit
Chamaerops serrulata fruit
Corypha obliqua fruit
Corypha repens fruit
Diglossophyllum serrulatum fruit
Sabal palm fruit
Sabal serrulata
Sabal serrulata fruit
Saw palmetto
Saw palmetto berry
Saw palmetto fruit
Saw palmetto whole
Serenoa
Serenoa repens
Serenoa repens fruit
Serenoa repens fruit dry extract
Serenoa repens fruit ethanol extract
Serenoa repens whole
Serenoa serrulata fruit
Serenoa serrulata fruit powder
Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: J7WWH9M8QS

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Hyperplasia 3 D011470 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108769
FDA SRS J7WWH9M8QS
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70